Q&A: Ireland's Success In Attracting Medtech Companies
Executive Summary
Medtech Insight talked to Rachel Shelly, the Head of Medical Technologies for IDA Ireland, about the Irish government's continuing efforts to attract medtech companies, the implications of Brexit, and the growing emphasis on data-analytics within the medtech industry in Ireland.
You may also be interested in...
MDR Changes Aren’t A ‘Catalyst’ For Medtech Investments In Ireland
IDA Ireland’s Rachel Shelly tells Medtech Insight about what is (and isn’t) driving investment in medtech.
Start-Up Spotlight: Vetex Brings Clot-Removal Technology To Venous System
The venous thrombectomy market has historically been under-served, especially compared to the arterial thrombectomy space, because the venous clots are more challenging to remove mechanically. But Galway, Ireland-based Vetex believes their technology, which combines a grasping and rotating action, will become the first-choice treatment for removal of large, difficult-to-remove venous clots in patients with venous thrombo-embolism, without the need for thrombolytic drugs.
New EU Notified Body Looks To Fill Gaps: Will Ireland-Based Group Provide Pressure Relief?
New to the EU notified body space, NSF Certification Ireland was among the first to apply for notified body designation under the new medtech regulations last November. The group hopes to help relieve the pressure that is expected to build up, in particular, due to the IVD Regulation, leader James Pink explains.